Subcutaneous midazolam, diamorphine and hyoscine infusion in palliative care of a child with neurodegenerative disease.
We report on the use of a subcutaneous infusion of diamorphine, hyoscine and midazolam in the terminal care of a child with a neurodegenerative disease. The technique was safe and effective, and provided good symptom relief including control of previously intractable seizures.
Grimshaw
D
D
Children's Hospital, Sheffield, UK.
Holroyd
E
E
Anthony
D
D
Hall
D M
DM
D017809:Fatal Outcome; D005260:Female; D003932:Heroin / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007223:Infant; D008874:Midazolam / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D010166:Palliative Care; D012601:Scopolamine / Q000627:therapeutic use*; D012640:Seizures / Q000517:prevention & control*
D006993:Hypnotics and Sedatives; D018727:Muscarinic Antagonists; D009294:Narcotics; D003932:Heroin; D012601:Scopolamine; D008874:Midazolam